Publication | Open Access

Chronic treatments with a 5-HT 4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease

Memory DeficitsAlzheimer's DiseaseDementiaNeuropharmacologyNeurochemical BiomarkersNeuroscienceNeurologyNeurodegenerationBrain PathologyMedicineMouse ModelChronic Treatments